Efficacy and safety benefits of HR17031 , a fixed‐ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open‐label, randomised, parallel three‐arm, treat‐to‐target trial

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Linong Ji, Debing Huang, Xiang Lin, Xue Dong, Lu Li, Qingyuan Sun, Xiaodong Sun, Li Mao, Shi Zhao, Quanren Wang, Zi Ye
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Diabetes, Obesity and Metabolism
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet